- Home
- SLS vs APT Comparison
SLS vs APT Comparison
Compare SLS & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- APT
- Stock Information
- Founded
- SLS 2012
- APT 1983
- Country
- SLS United States
- APT Canada
- Employees
- SLS N/A
- APT N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- SLS Health Care
- APT
- Exchange
- SLS Nasdaq
- APT Nasdaq
- Market Cap
- SLS 75.3M
- APT 61.6M
- IPO Year
- SLS N/A
- APT 1995
- Fundamental
- Price
- SLS $0.90
- APT $5.08
- Analyst Decision
- SLS
- APT
- Analyst Count
- SLS 0
- APT 0
- Target Price
- SLS N/A
- APT N/A
- AVG Volume (30 Days)
- SLS 1.6M
- APT 33.4K
- Earning Date
- SLS 11-13-2024
- APT 11-06-2024
- Dividend Yield
- SLS N/A
- APT N/A
- EPS Growth
- SLS N/A
- APT 20.88
- EPS
- SLS N/A
- APT 0.37
- Revenue
- SLS N/A
- APT $59,288,000.00
- Revenue This Year
- SLS N/A
- APT N/A
- Revenue Next Year
- SLS N/A
- APT N/A
- P/E Ratio
- SLS N/A
- APT $14.17
- Revenue Growth
- SLS N/A
- APT 1.88
- 52 Week Low
- SLS $0.50
- APT $4.64
- 52 Week High
- SLS $1.72
- APT $6.92
- Technical
- Relative Strength Index (RSI)
- SLS 30.01
- APT 42.27
- Support Level
- SLS $0.86
- APT $5.06
- Resistance Level
- SLS $0.98
- APT $5.33
- Average True Range (ATR)
- SLS 0.11
- APT 0.22
- MACD
- SLS -0.02
- APT 0.01
- Stochastic Oscillator
- SLS 21.74
- APT 50.72
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.